Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada

NCT02367222 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT02367222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02367222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada
Lead sponsor
University of Manitoba
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2015
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis